| 期刊論文| 1. | Ben-Ami, R.、Rodriguez-Bano, J.、Arslan, H.、Pitout, J. D.、Quentin, C.、Calbo, E. S.、Carmeli, Y.(2009)。A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients。Clin Infect Dis，49(5)，682-690。   | | 2. | Paterson, D. L.、Ko, W. C.、Von Gottberg, A.、Mohapatra, S.、Casellas, J. M.、Goossens, H.、Yu, V. L.(2004)。International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum betalactamase production in nosocomial Infections。Ann Intern Med，140(1)，26-32。 | | 3. | Jacoby, G. A.、Munoz-Price, L. S.(2005)。The new beta-lactamases。N Engl J Med，352(4)，380-391。 | | 4. | Park, Y. S.、Adams-Haduch, J. M.、Shutt, K. A.、Yarabinec, D. M.、Johnson, L. E.、Hingwe, A.、Doi, Y.(2012)。Clinical and microbiologic characteristics of cephalosporin-resistant Escherichia coli at three centers in the United States。Antimicrob Agents Chemother，56(4)，1870-1876。 | | 5. | Kang, C. I.、Wi, Y. M.、Lee, M. Y.、Ko, K. S.、Chung, D. R.、Peck, K. R.、Song, J. H.(2012)。Epidemiology and risk factors of community onset infections caused by extended-spectrum beta-lactamase-producing Escherichia coli strains。J Clin Microbiol，50(2)，312-317。 | | 6. | Rodriguez-Bano, J.、Picon, E.、Gijon, P.、Hernandez, J. R.、Ruiz, M.、Pena, C.、Spanish Network for Research in Infectious, D.(2010)。Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis。Clin Infect Dis，50(1)，40-48。 | | 7. | Bert, F.、Larroque, B.、Paugam-Burtz, C.、Dondero, F.、Durand, F.、Marcon, E.、Nicolas-Chanoine, M. H.(2012)。Pretransplant Fecal Carriage of Extended-Spectrum β-Lactamase–producing Enterobacteriaceae and Infection after Liver Transplant, France。Emerg Infect Dis，18(6)，908-916。 | | 8. | Paterson, D. L.、Ko, W. C.、Von Gottberg, A.、Mohapatra, S.、Casellas, J. M.、Goossens, H.、Yu, V. L.(2004)。Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extendedspectrum beta-lactamases。Clin Infect Dis，39(1)，31-37。 | | 9. | Zanetti, G.、Bally, F.、Greub, G.、Garbino, J.、Kinge, T.、Lew, D.、Cefepime Study, G.(2003)。Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study。Antimicrob Agents Chemother，47(11)，3442-3447。 | | 10. | Lee, C. H.、Su, L. H.、Tang, Y. F.、Liu, J. W.(2006)。Treatment of ESBL-producing Klebsiella pneumoniae bacteraemia with carbapenems or flomoxef: a retrospective study and laboratory analysis of the isolates。J Antimicrob Chemother，58(5)，1074-1077。 | | 11. | Vardakas, K. Z.、Tansarli, G. S.、Rafailidis, P. I.、Falagas, M. E.(2012)。Carbapenems versus alternative antibiotics for the treatment of bacteraemia due to Enterobacteriaceae produc ing ext ended-spectrumbeta-lactamases: a systematic review and metaanalysis。J Antimicrob Chemother，67(12)，2793-2803。 | | 12. | Lee, N. Y.、Lee, C. C.、Huang, W. H.、Tsui, K. C.、Hsueh, P. R.、Ko, W. C.(2012)。Carbapenem therapy for bacteremia due to extended-spectrum-beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae: implications of ertapenem susceptibility。Antimicrob Agents Chemother，56(6)，2888-2893。 | | 13. | Tamma, P. D.、Han, J. H.、Rock, C.、Harris, A. D.、Lautenbach, E.、Hsu, A. J.、Antibacterial Resistance Leadership, G.(2015)。Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum beta-lactamase bacteremia。Clin Infect Dis，60(9)，1319-1325。 | | 14. | Lee, C. H.、Su, L. H.、Chen, F. J.、Tang, Y. F.、Li, C. C.、Chien, C. C.、Liu, J. W.(2015)。Comparative effectiveness of flomoxef versus carbapenems in the treatment of bacteraemia due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae with emphasis on minimum inhibitory concentration of flomoxef: a retrospective study。Int J Antimicrob Agents，46(6)，610-615。 | | 15. | Celikbilek, N.、Gozalan, A.、Ozdem, B.、Kirca, F.、Acikgoz, Z. C.(2015)。Extended-spectrum beta-lactamase production by Enterobacteriaceae isolates from urine cultures of outpatients: results of a 7-year follow-up。Mikrobiyol Bul，49(2)，259-265。 | | 16. | Yamamoto, A.、Yamasaki, K.(2015)。Evaluation of antibiotic treatments for urinary tract infections in the elderly, especially regarding the effect on extended spectrum beta-lactamase producing (ESBL-) Escherichia coli: A comparison between meropenem and alternatives。Nihon Ronen Igakkai Zasshi，52(2)，153-161。 | |
| |